Nuclear receptors as therapeutic targets in cholestatic liver diseases
Open accessAbstract
Cholestasis results in intrahepatic accumulation of cytotoxic bile acids, which cause liver damage ultimately leading to biliary fibrosis and cirrhosis. Cholestatic liver injury is counteracted by a variety of adaptive hepatoprotective mechanisms including alterations in bile acid transport, synthesis and detoxification. The underlying molecular mechanisms are mediated mainly at a transcriptional level via a complex network involving nuclear receptors including the farnesoid X receptor, pregnane X receptor, vitamin D receptor and constitutive androstane receptor, which target overlapping, although not identical, sets of genes. Because the intrinsic adaptive response to bile acids cannot fully prevent liver injury in cholestasis, therapeutic targeting of these receptors via specific and potent agonists may further enhance the hepatic defence against toxic bile acids. Activation of these receptors results in repression of bile acid synthesis, induction of phases I and II bile acid hydroxylation and conjugation and stimulation of alternative bile acid export while limiting hepatocellular bile acid import. Furthermore, the use of nuclear receptor ligands may not only influence bile acid transport and metabolism but may also directly target hepatic fibrogenesis and inflammation. Many drugs already used to treat cholestasis and its complications such as pruritus (e.g. ursodeoxycholic acid, rifampicin, fibrates) may act via activation of nuclear receptors. More specific and potent nuclear receptor ligands are currently being developed. This article will review the current knowledge on nuclear receptors and their potential role in the treatment of cholestatic liver diseases.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Nuclear receptors are ligand-activated transcription factors that regulate gene expression of key molecular signals involved in liver fibrosis.
“Nuclear receptors are ligand-activated transcription factors that regulate gene expression of a variety of key molecular signals involved in liver fibrosis.”
From Nuclear receptors in liver fibrosis (2021) · cites this paper as [25]
All nuclear receptors share a common structure that allows them to bind directly to DNA and regulate gene transcription.
“All NRs share a common structure which allows them to bind directly to DNA and regulate gene transcription.[25]”
From Nuclear receptors in liver fibrosis (2021) · cites this paper as [25]
Nuclear receptors play a pivotal role in the overall control of several biological processes and represent a promising target in liver diseases.
“NRs in general, play a pivotal role in the overall control of several biological processes and represent a promising target in liver diseases.[25]”
From Nuclear receptors in liver fibrosis (2021) · cites this paper as [25]
In addition to FXR, other nuclear receptors such as PXR, CAR and VDR are activated by certain bile acids.
“In addition to FXR also other NRs such as the pregnane X receptor (PXR/NR1I2), the constitutive androstane receptor (CAR/NR1I3) and the vitamin D receptor (NR1I1) are activated via certain BAs.45”
From Novel therapeutic targets for cholestatic and fatty liver disease (2022) · cites this paper as [45]
Pharmacological activation of FXR restores BA homoeostasis by stimulating BSEP transcription, reducing BA uptake and synthesis, and stimulating alternative basolateral export, thereby reducing hepatic BA load and alleviating BA-mediated cellular stress in cholestasis.
“pharmacological activation of FXR restores BA homoeostasis by stimulation of transcription of the bile salt export pump that mediates the rate-limiting step in hepatocellular BA excretion across the canalicular membrane. Together with a reduction of BA uptake systems Na +- taurocholate cotransporting polypeptide (NTCP) and synthesis (CYP7A1) as well as stimulation of alternative basolateral export”
From Novel therapeutic targets for cholestatic and fatty liver disease (2022) · cites this paper as [45]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
The RXR heterodimers and orphan receptors
Mangelsdorf, D. J., & Evans, R. M. (1995) · Cell · doi:10.1016/0092-8674(95)90200-7 · Cited by 3,133 · see citing works
Bile Acids: Natural Ligands for an Orphan Nuclear Receptor
Parks, D. J., Blanchard, S. G., Bledsoe, R. K., Chandra, G., Consler, T. G., Kliewer, S. A., Stimmel, J. B., Willson, T. M., Zavacki, A. M., Moore, D. D., et al. (1999) · Science · doi:10.1126/science.284.5418.1365 · Cited by 2,274 · see citing works
The coregulator exchange in transcriptional functions of nuclear receptors
Glass, C. K., & Rosenfeld, M. G. (2000) · Genes & Development · doi:10.1101/gad.14.2.121 · Cited by 2,233 · see citing works
Nuclear Receptors and Lipid Physiology: Opening the X-Files
Chawla, A., Repa, J. J., Evans, R. M., & Mangelsdorf, D. J. (2001) · Science · doi:10.1126/science.294.5548.1866 · Cited by 2,085 · see citing works
A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis
Goodwin, B., Jones, S. A., Price, R. R., Watson, M. A., McKee, D. D., Moore, L. B., Galardi, C., Wilson, J. G., Lewis, M. C., Roth, M. E., et al. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)00051-4 · Cited by 1,940 · see citing works
Nuclear Receptor Coregulators: Cellular and Molecular Biology
McKenna, N. J., Lanz, R. B., & O’Malley, B. W. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.3.0366 · Cited by 1,905 · see citing works
Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis
Inagaki, T., Choi, M., Moschetta, A., Peng, L., Cummins, C. L., McDonald, J. G., Luo, G., Jones, S. A., Goodwin, B., Richardson, J. A., et al. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.09.001 · Cited by 1,865 · see citing works
A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis
Belfort, R., Harrison, S. A., Brown, K., Darland, C., Finch, J., Hardies, J., Balas, B., Gastaldelli, A., Tio, F., Pulcini, J., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa060326 · Cited by 1,827 · see citing works
Targeted Disruption of the Nuclear Receptor FXR/BAR Impairs Bile Acid and Lipid Homeostasis
Sinal, C. J., Tohkin, M., Miyata, M., Ward, J. M., Lambert, G., & Gonzalez, F. J. (2000) · Cell · doi:10.1016/s0092-8674(00)00062-3 · Cited by 1,819 · see citing works
The PPARs: From Orphan Receptors to Drug Discovery
Willson, T. M., Brown, P. J., Sternbach, D. D., & Henke, B. R. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm990554g · Cited by 1,816 · see citing works
An oxysterol signalling pathway mediated by the nuclear receptor LXRα
Janowski, B. A., Willy, P. J., Devi, T. R., Falck, J. R., & Mangelsdorf, D. J. (1996) · Nature · doi:10.1038/383728a0 · Cited by 1,754 · see citing works
Mutations in the hepatocyte nuclear factor-1α gene in maturity-onset diabetes of the young (MODY3)
Yamagata, K., Oda, N., Kaisaki, P. J., Menzel, S., Furuta, H., Vaxillaire, M., Southam, L., Cox, R., Lathrop, M. G., Boriraj, V. V., et al. (1996) · Nature · doi:10.1038/384455a0 · Cited by 1,610 · see citing works
Lee, W. M. (2003) · New England Journal of Medicine · doi:10.1056/nejmra021844 · Cited by 1,594 · see citing works
Lehmann, J., McKee, D. D., Watson, M. A., Willson, T. M., Moore, J. T., & Kliewer, S. A. (1998) · Journal of Clinical Investigation · doi:10.1172/jci3703 · Cited by 1,577 · see citing works
Molecular Basis for Feedback Regulation of Bile Acid Synthesis by Nuclear Receptors
Lu, T. T., Makishima, M., Repa, J. J., Schoonjans, K., Kerr, T. A., Auwerx, J., & Mangelsdorf, D. J. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)00050-2 · Cited by 1,487 · see citing works
PGC-1 coactivators: inducible regulators of energy metabolism in health and disease
Finck, B. N. (2006) · Journal of Clinical Investigation · doi:10.1172/jci27794 · Cited by 1,427 · see citing works
The nuclear receptor PXR is a lithocholic acid sensor that protects against liver toxicity
Staudinger, J. L., Goodwin, B. J., Jones, S. A., Hawkins‐Brown, D., MacKenzie, K. I., Latour, A. M., Liu, Y., Klaassen, C. D., Brown, K. K., Reinhard, J. F., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.051551698 · Cited by 1,378 · see citing works
Control of Pancreas and Liver Gene Expression by HNF Transcription Factors
Odom, D. T., Zizlsperger, N., Gordon, D. B., Bell, G. W., Rinaldi, N. J., Murray, H. L., Volkert, T. L., Schreiber, J., Rolfe, A., Gifford, D. K., et al. (2004) · Science · doi:10.1126/science.1089769 · Cited by 1,312 · see citing works
A SUMOylation-dependent pathway mediates transrepression of inflammatory response genes by PPAR-γ
Pascual, G., Fong, A. L., Ogawa, S., Gamliel, A., Li, A. C., Perissi, V., Rose, D. W., Willson, T. M., Rosenfeld, M. G., & Glass, C. K. (2005) · Nature · doi:10.1038/nature03988 · Cited by 1,251 · see citing works
Activation of the Nuclear Receptor LXR by Oxysterols Defines a New Hormone Response Pathway
Lehmann, J. M., Kliewer, S. A., Moore, L. B., Smith-Oliver, T. A., Oliver, B. B., Su, J.-L., Sundseth, S. S., Winegar, D. A., Blanchard, D. E., Spencer, T. A., et al. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.6.3137 · Cited by 1,233 · see citing works
Vitamin D Receptor As an Intestinal Bile Acid Sensor
Makishima, M., Lu, T. T., Xie, W., Whitfield, G. K., Domoto, H., Evans, R. M., Haussler, M. R., & Mangelsdorf, D. J. (2002) · Science · doi:10.1126/science.1070477 · Cited by 1,176 · see citing works
Regulation of antibacterial defense in the small intestine by the nuclear bile acid receptor
Inagaki, T., Moschetta, A., Lee, Y.-K., Peng, L., Zhao, G., Downes, M., Yu, R. T., Shelton, J. M., Richardson, J. A., Repa, J. J., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0509592103 · Cited by 1,164 · see citing works
Reciprocal regulation of inflammation and lipid metabolism by liver X receptors
Joseph, S. B., Castrillo, A., Laffitte, B. A., Mangelsdorf, D. J., & Tontonoz, P. (2003) · Nature Medicine · doi:10.1038/nm820 · Cited by 1,158 · see citing works
Sladek, F. M., Zhong, W. M., Lai, E., & Darnell, J. E. (1990) · Genes & Development · doi:10.1101/gad.4.12b.2353 · Cited by 1,027 · see citing works
Bile salt transporters: molecular characterization, function, and regulation
Trauner, M., & Boyer, J. L. (2003) · Physiological Reviews · doi:10.1152/physrev.00027.2002 · Cited by 999 · see citing works
Self-citationStrautnieks, S. S., Bull, L. N., Knisely, A. S., Kocoshis, S. A., Dahl, N., Arnell, H., Sokal, E. M., Dahan, K., Childs, S. J., Ling, V. W. T., et al. (1998) · Nature Genetics · doi:10.1038/3034 · Cited by 988 · see citing works
Liver X receptors as integrators of metabolic and inflammatory signaling
Zelcer, N. (2006) · Journal of Clinical Investigation · doi:10.1172/jci27883 · Cited by 978 · see citing works
Mutations in the hepatocyte nuclear factor-4α gene in maturity-onset diabetes of the young (MODY1)
Yamagata, K., Furuta, H., Oda, N., Kaisaki, P. J., Menzel, S., Cox, N. J., Fajans, S. S., Signorini, S. G., Stoffel, M., & Bell, G. I. (1996) · Nature · doi:10.1038/384458a0 · Cited by 975 · see citing works
Kast, H. R., Goodwin, B., Tarr, P. T., Jones, S. A., Anisfeld, A. M., Stoltz, C. M., Tontonoz, P., Kliewer, S., Willson, T. M., & Edwards, P. A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m109326200 · Cited by 916 · see citing works
Identification of a human nuclear receptor defines a new signaling pathway for CYP 3 A induction
Bertilsson, G., Heidrich, J., Svensson, K., Åsman, M., Jendeberg, L., Sydow‐Báckman, M., OHLSSON, R. I., Postlind, H., Blomquist, P., & Berkenstam, A. L. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.21.12208 · Cited by 873 · see citing works
Repa, J. J., Berge, K. E., Pomajzl, C., Richardson, J. A., Hobbs, H. H., & Mangelsdorf, D. J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m109927200 · Cited by 852 · see citing works
Ananthanarayanan, M., Balasubramanian, N., Makishima, M., Mangelsdorf, D. J., & Suchy, F. J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m011610200 · Cited by 804 · see citing works
Nuclear Receptor Coregulators: Cellular and Molecular Biology
McKenna, N. J. (1999) · Endocrine Reviews · doi:10.1210/er.20.3.321 · Cited by 782 · see citing works
An essential role for nuclear receptors SXR/PXR in detoxification of cholestatic bile acids
Xie, W., Radominska-p, A., Shi, Y., Simon, C. M., Nelson, M. C., Ong, E. S., Waxman, D. J., & Evans, R. M. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.051014398 · Cited by 751 · see citing works
Molecular Pathogenesis of Cholestasis
Trauner, M. A., Meier, P. J., & Boyer, J. L. (1998) · New England Journal of Medicine · doi:10.1056/nejm199810223391707 · Cited by 701 · see citing works
Self-citationHolt, J. A., Luo, G., Billin, A. N., Bisi, J., McNeill, Y. Y., Kozarsky, K., Donahee, M. H., Wang, D. Y., Mansfield, T. A., Kliewer, S. A., et al. (2003) · Genes & Development · doi:10.1101/gad.1083503 · Cited by 698 · see citing works
An overview on biological mechanisms of PPARs
Kota, B. P., Huang, T. H.-W., & Roufogalis, B. D. (2004) · Pharmacological Research · doi:10.1016/j.phrs.2004.07.012 · Cited by 671 · see citing works
Nuclear Receptor-Dependent Bile Acid Signaling Is Required for Normal Liver Regeneration
Huang, W., Ma, K., Zhang, J., Qatanani, M., Cuvillier, J., Liu, J., Dong, B., Huang, X., & Moore, D. D. (2006) · Science · doi:10.1126/science.1121435 · Cited by 645 · see citing works
Molecular Pathogenesis of Cholestasis
Trauner, M. A., & Jansen, P. L. M. (2004) · Springer eBooks · doi:10.1007/978-1-4419-9034-1 · Cited by 612 · see citing works
Self-citationEnzymology of human cytosolic sulfotransferases
Falany, C. N. (1997) · The FASEB Journal · doi:10.1096/fasebj.11.4.9068609 · Cited by 604 · see citing works
Kim, I., Ahn, S.-H., Inagaki, T., Choi, M., Ito, S., Guo, G. L., Kliewer, S., & Gonzalez, F. (2007) · Journal of Lipid Research · doi:10.1194/jlr.m700330-jlr200 · Cited by 575 · see citing works
Ghisletti, S., Huang, W., Ogawa, S., Pascual, G., Lin, M.-E., Willson, T. M., Rosenfeld, M. G., & Glass, C. K. (2007) · Molecular Cell · doi:10.1016/j.molcel.2006.11.022 · Cited by 561 · see citing works
Regulation of bile acid synthesis: pathways, nuclear receptors, and mechanisms
Chiang, J. Y. L. (2003) · Journal of Hepatology · doi:10.1016/j.jhep.2003.11.006 · Cited by 550 · see citing works
Myant, N. B., & Mitropoulos, K. A. (1977) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)41693-1 · Cited by 521 · see citing works
Fatty acyl-CoA thioesters are ligands of hepatic nuclear factor-4α
Hertz, R., Magenheim, J., Berman, I., & Bar‐Tana, J. (1998) · Nature · doi:10.1038/33185 · Cited by 509 · see citing works
Controlling nuclear receptors: the circular logic of cofactor cycles
Perissi, V., & Rosenfeld, M. G. (2005) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1680 · Cited by 507 · see citing works
Almé, B., Bremmelgaard, A., Sjövall, J., & Thomassen, P. A. B. (1977) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)41684-0 · Cited by 491 · see citing works
Mammalian hepatocyte differentiation requires the transcription factor HNF-4alpha.
(2000) · PubMed Central · Cited by 489 · see citing works
Yang, F., Huang, X., Yi, T., Yen, Y., Moore, D. D., & Huang, W. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-1078 · Cited by 488 · see citing works
Pineda‐Torra, I., Claudel, T., Duval, C., Kosykh, V., Fruchart, J., & Staels, B. (2003) · Molecular Endocrinology · doi:10.1210/me.2002-0120 · Cited by 485 · see citing works
Redundant Pathways for Negative Feedback Regulation of Bile Acid Production
Wang, L., Lee, Y., Bundman, D. S., Han, Y., Thevananther, S., Kim, C.-S., Chua, S. S., Wei, P. Y., Heyman, R. A., Karin, M., et al. (2002) · Developmental Cell · doi:10.1016/s1534-5807(02)00187-9 · Cited by 475 · see citing works
Ou, J., Tu, H., Shan, B., Luk, A. Y., DeBose‐Boyd, R. A., Bashmakov, Y. K., Goldstein, J. L., & Brown, M. S. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.111138698 · Cited by 474 · see citing works
Fiorucci, S., Antonelli, E., Rizzo, G., Renga, B., Mencarelli, A., Riccardi, L., Orlandi, S., Pellicciari, R., & Morelli, A. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.08.001 · Cited by 472 · see citing works
Induction of Drug Metabolism: The Role of Nuclear Receptors
Handschin, C., & Meyer, U. (2003) · Pharmacological Reviews · doi:10.1124/pr.55.4.2 · Cited by 467 · see citing works
Denson, L. A., Sturm, E., Echevarría, W., Zimmerman, T. L., Makishima, M., Mangelsdorf, D. J., & Karpen, S. J. (2001) · Gastroenterology · doi:10.1053/gast.2001.25503 · Cited by 460 · see citing works
Mammalian hepatocyte differentiation requires the transcription factor HNF-4αPreprint
Li, J., Ning, G., & Duncan, S. A. (2000) · Genes & Development · doi:10.1101/gad.14.4.464 · Cited by 458 · see citing works
LRH-1: an orphan nuclear receptor involved in development, metabolism and steroidogenesis.
Fayard, E., Auwerx, J., & Schoonjans, K. (2004) · Trends in Cell Biology · doi:10.1016/j.tcb.2004.03.008 · Cited by 445 · see citing works
Galli, A., Crabb, D. W., Ceni, E., Salzano, R., Mello, T., Svegliati–Baroni, G., Ridolfi, F., Trozzi, L., Surrenti, C., & Casini, A. (2002) · Gastroenterology · doi:10.1053/gast.2002.33666 · Cited by 440 · see citing works
The orphan nuclear receptor HNF4α determines PXR- and CAR-mediated xenobiotic induction of CYP3A4
Tirona, R. G., Lee, W., Leake, B. F., Lan, L.-B., Cline, C., Lamba, V., Parviz, F., Duncan, S. A., Inoue, Y., Gonzalez, F. J., et al. (2003) · Nature Medicine · doi:10.1038/nm815 · Cited by 436 · see citing works
King, C., Rios, G. R., Green, M. D., & Tephly, T. R. (2000) · Current Drug Metabolism · doi:10.2174/1389200003339171 · Cited by 432 · see citing works
Shih, D. Q., Bussen, M., Sehayek, E., Ananthanarayanan, M., Shneider, B. L., Suchy, F. J., Shefer, S., Bollileni, J. S., Gonzalez, F. J., Breslow, J. L., et al. (2001) · Nature Genetics · doi:10.1038/86871 · Cited by 422 · see citing works
Sulfation and sulfotransferases 1: Sulfotransferase molecular biology: cDNAs and genes.
Weinshilboum, R. M., Otterness, D. M., Aksoy, I. A., Wood, T. C., Her, C., & Raftogianis, R. B. (1997) · PubMed · Cited by 408 · see citing works
Krylova, I. N., Sablin, E. P., Moore, J. M. R., Xu, R. X., Waitt, G. M., MacKay, J. A., JUZUMIENE, D. I., Bynum, J. M., Madauss, K. P., Montana, V. G., et al. (2005) · Cell · doi:10.1016/j.cell.2005.01.024 · Cited by 405 · see citing works
Schuetz, E. G., Strom, S. C., Yasuda, K., Lecureur, V., Assem, M., Brimer, C., Lamba, J. K., Kim, R. B., Ramachandran, V., Komoroski, B. J., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m106340200 · Cited by 395 · see citing works
Regulation of bile acid synthesis
Chiang, J. Y. L. (1998) · Frontiers in bioscience · doi:10.2741/a273 · Cited by 393 · see citing works
Induction of bilirubin clearance by the constitutive androstane receptor (CAR)
Huang, W., Zhang, J., Chua, S. S., Qatanani, M., Han, Y., Granata, R., & Moore, D. D. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0630614100 · Cited by 390 · see citing works
BAREing it all: the adoption of LXR and FXR and their roles in lipid homeostasis
Edwards, P. A., Kast-Woelbern, H. R., & Anisfeld, A. M. (2002) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)30180-2 · Cited by 387 · see citing works
Dawson, P. A., Hubbert, M. L., Haywood, J., Craddock, A. L., Zerangue, N., Christian, W. V., & Ballatori, N. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m412752200 · Cited by 381 · see citing works
Chiang, J. Y. L., Kimmel, R., & Stroup, D. (2001) · Gene · doi:10.1016/s0378-1119(00)00518-7 · Cited by 374 · see citing works
Pascussi, J., Drocourt, L., Fabre, J., Maurel, P., & Vilarem, M. (2000) · Molecular Pharmacology · doi:10.1124/mol.58.2.361 · Cited by 371 · see citing works
Sulfotransferase molecular biology: cDNAs and genes
Weinshilboum, R. M., Otterness, D. M., Aksoy, I. A., Wood, T. C., Her, C., & Raftogianis, R. B. (1997) · The FASEB Journal · doi:10.1096/fasebj.11.1.9034160 · Cited by 369 · see citing works
Xie, W., Yeuh, M.-F., Radominska-p, A., Saini, S. P. S., Negishi, Y., Bottroff, B. S., Cabrera, G. Y., Tukey, R. H., & Evans, R. M. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0438010100 · Cited by 367 · see citing works
Zhang, Y., Castellani, L. W., Sinal, C. J., Gonzalez, F. J., & Edwards, P. A. (2004) · Genes & Development · doi:10.1101/gad.1138104 · Cited by 367 · see citing works
Zollner, G. (2001) · Hepatology · doi:10.1053/jhep.2001.22646 · Cited by 359 · see citing works
Self-citationSpontaneous hepatocarcinogenesis in farnesoid X receptor-null mice
Kim, I., Morimura, K., Shah, Y., Yang, Q., Ward, J. M., & Gonzalez, F. J. (2007) · Carcinogenesis · doi:10.1093/carcin/bgl249 · Cited by 357 · see citing works
Orphan Nuclear Receptors as eLiXiRs and FiXeRs of Sterol Metabolism
Lu, T. T., Repa, J. J., & Mangelsdorf, D. J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.r100035200 · Cited by 356 · see citing works
Wagner, M., Halilbasic, E., Marschall, H., Zollner, G., Fickert, P., Langner, C., Zatloukal, K., Denk, H., & Trauner, M. (2005) · Hepatology · doi:10.1002/hep.20784 · Cited by 355 · see citing works
Self-citationYamamoto, Y., Moore, R., Goldsworthy, T. L., Negishi, M., & Maronpot, R. R. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1459 · Cited by 350 · see citing works
FXR, a multipurpose nuclear receptor
Lee, F. Y., Lee, H., Hubbert, M. L., Edwards, P. A., & Zhang, Y. (2006) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2006.08.002 · Cited by 344 · see citing works
Peroxisome Proliferator–Activated Receptors as Transcriptional Nodal Points and Therapeutic Targets
Brown, J. D., & Plutzky, J. (2007) · Circulation · doi:10.1161/circulationaha.104.475673 · Cited by 338 · see citing works
Zollner, G., Marschall, H., Wagner, M., & Trauner, M. A. (2006) · Molecular Pharmaceutics · doi:10.1021/mp060010s · Cited by 334 · see citing works
Self-citationPascussi, J., Gerbal‐Chaloin, S., Drocourt, L., Maurel, P., & Vilarem, M. (2003) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/s0304-4165(02)00483-x · Cited by 330 · see citing works
Regulation ofCYP3AGene Transcription by the Pregnane X Receptor
Goodwin, B. J., Redinbo, M. R., & Kliewer, S. A. (2002) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.42.111901.111051 · Cited by 328 · see citing works
Prevention of cholesterol gallstone disease by FXR agonists in a mouse model
Moschetta, A., Bookout, A. L., & Mangelsdorf, D. J. (2004) · Nature Medicine · doi:10.1038/nm1138 · Cited by 326 · see citing works
Marschall, H., Wagner, M., Zollner, G., Fickert, P., Diczfalusy, U., Gumhold, J., Silbert, D., Fuchsbichler, A., Benthin, L., Grundström, R., et al. (2005) · Gastroenterology · doi:10.1016/j.gastro.2005.05.009 · Cited by 321 · see citing works
Self-citationLadias, J. A. A., Hadzopoulou‐Cladaras, M., Kardassis, D., Cardot, P., Cheng, J., Zannis, V. I., & Cladaras, C. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)49613-0 · Cited by 317 · see citing works
Fickert, P., Zollner, G., Fuchsbichler, A., Stumptner, C., Weiglein, A. H., Lammert, F., Marschall, H., Tsybrovskyy, O., Zatloukal, K., Denk, H., et al. (2002) · Gastroenterology · doi:10.1053/gast.2002.35948 · Cited by 312 · see citing works
Self-citationGuo, G. L., Lambert, G., Negishi, M., Ward, J. M., Brewer, H. B., Kliewer, S. A., Gonzalez, F. J., & Sinal, C. J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m307145200 · Cited by 312 · see citing works
Hepatocyte nuclear factor 4 is a transcription factor that constitutively binds fatty acids
Wisely, G. B., Miller, A. B., Davis, R. G., Thornquest, A. D., Johnson, R., Spitzer, T., Sefler, A., Shearer, B., Moore, J. T., Miller, A. B., et al. (2002) · Structure · doi:10.1016/s0969-2126(02)00829-8 · Cited by 311 · see citing works
Lee, Y., Dell, H., Dowhan, D. H., Hadzopoulou‐Cladaras, M., & Moore, D. D. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.1.187-195.2000 · Cited by 307 · see citing works
Chiang, J. Y. L., Kimmel, R., Weinberger, C., & Stroup, D. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.15.10918 · Cited by 304 · see citing works
Funk, C., Ponelle, C., Scheuermann, G., & Pantze, M. P. (2001) · Molecular Pharmacology · doi:10.1124/mol.59.3.627 · Cited by 295 · see citing works
Hepatic Transport of Bile Salts
Kullak-Ublick, G. A., Stieger, B., Hagenbuch, B., & Meier, P. J. (2000) · Seminars in Liver Disease · doi:10.1055/s-2000-9426 · Cited by 292 · see citing works
Up–Regulation of Basolateral Multidrug Resistance Protein 3 (Mrp3) in Cholestatic Rat Liver
Donner, M. G., & KEPPLER, D. O. R. (2001) · Hepatology · doi:10.1053/jhep.2001.26213 · Cited by 291 · see citing works
Plass, J. R. M., Mol, O., Heegsma, J., Geuken, M., Faber, K. N., Jansen, P. L. M., & Müller, M. M. (2002) · Hepatology · doi:10.1053/jhep.2002.31724 · Cited by 291 · see citing works
Soroka, C. J., Lee, J. M., Azzaroli, F., & Boyer, J. L. (2001) · Hepatology · doi:10.1053/jhep.2001.23501 · Cited by 288 · see citing works
Crystal Structure of the HNF4α Ligand Binding Domain in Complex with Endogenous Fatty Acid Ligand
Dhe‐Paganon, S., Duda, K. M., Iwamoto, M. A., Chi, Y., & Shoelson, S. E. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.c200420200 · Cited by 287 · see citing works
Huang, W., Zhang, J., Washington, M., Liu, J., Parant, J. M., Lozano, G., & Moore, D. D. (2005) · Molecular Endocrinology · doi:10.1210/me.2004-0520 · Cited by 284 · see citing works
Regulation of a xenobiotic sulfonation cascade by nuclear pregnane X receptor (PXR)
Sonoda, J., Xie, W., Rosenfeld, J. M., Barwick, J. L., Guzelian, P. S., & Evans, R. M. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.212494599 · Cited by 281 · see citing works
Nitta, M., Ku, S., Brown, C., Okamoto, A. Y., & Shan, B. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.12.6660 · Cited by 279 · see citing works
Adaptive changes in hepatobiliary transporter expression in primary biliary cirrhosis
Zollner, G., Fickert, P., Silbert, D., Fuchsbichler, A., Marschall, H., Zatloukal, K., Denk, H., & Trauner, M. A. (2003) · Journal of Hepatology · doi:10.1016/s0168-8278(03)00096-5 · Cited by 275 · see citing works
Self-citationLaffitte, B. A., Kast-Woelbern, H. R., Nguyen, C., Zavacki, A. M., Moore, D. D., & Edwards, P. A. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.14.10638 · Cited by 275 · see citing works
Hirohashi, T., Suzuki, H., Ito, K., Ogawa, K., Kume, K., Shimizu, T., & Sugiyama, Y. (1998) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)13278-6 · Cited by 265 · see citing works
Wagner, M., Fickert, P., Zollner, G., Fuchsbichler, A., Silbert, D., Tsybrovskyy, O., Zatloukal, K., Guo, G. L., Schuetz, J. D., Gonzalez, F. J., et al. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)01068-0 · Cited by 264 · see citing works
Self-citationCoordinate regulation of xenobiotic and bile acid homeostasis by pregnane X receptor.
Staudinger, J. L., Liu, Y., Madan, A., Habeebu, S. S., & Klaassen, C. D. (2001) · PubMed · Cited by 260 · see citing works
Coordinate transcriptional regulation of bile acid homeostasis and drug metabolism
Eloranta, J. J., & Kullak-Ublick, G. A. (2005) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2004.09.019 · Cited by 260 · see citing works
Marschall, H., Wagner, M., Zollner, G., et al. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.05.009 · Cited by 258 · see citing works
Self-citationFickert, P., Zollner, G., Fuchsbichler, A., Stumptner, C., Pojer, C., Zenz, R., Lammert, F., Stieger, B., Meier, P. J., Zatloukal, K., et al. (2001) · Gastroenterology · doi:10.1053/gast.2001.25542 · Cited by 257 · see citing works
Self-citationvan Mil, S. W. C., Milona, A., Dixon, P. H., Müllenbach, R., Geenes, V. L., Chambers, J., Shevchuk, V., Moore, G. E., Lammert, F., Glantz, A., et al. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.05.015 · Cited by 257 · see citing works
Maher, J. M., Cheng, X., Slitt, A. L., Dieter, M. Z., & Klaassen, C. D. (2005) · Drug Metabolism and Disposition · doi:10.1124/dmd.105.003798 · Cited by 255 · see citing works
Transcriptional Regulation of the Human CYP3A4Gene by the Constitutive Androstane Receptor
Goodwin, B. J., Hodgson, E., D'Costa, D. J., et al. (2002) · Molecular Pharmacology · doi:10.1124/mol.62.2.359 · Cited by 254 · see citing works
Characterization of inducible nature of MRP3 in rat liver
Ogawa, K., Suzuki, H. I., Hirohashi, T., et al. (2000) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.2000.278.3.g438 · Cited by 254 · see citing works
Gascon-Barré, M., Demers, C., Mirshahi, A., Néron, S., Zalzal, S., & Nanci, A. (2003) · Hepatology · doi:10.1053/jhep.2003.50176 · Cited by 254 · see citing works
Chen, F., Ma, L., Dawson, P. A., Sinal, C. J., Sehayek, E., Gonzalez, F. J., Breslow, J. L., Ananthanarayanan, M., & Shneider, B. L. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m207903200 · Cited by 253 · see citing works
Saini, S. P. S., Sonoda, J., Xu, L., Toma, D., Uppal, H., Mu, Y., Ren, S., Moore, D. D., Evans, R. M., & Xie, W. (2004) · Molecular Pharmacology · doi:10.1124/mol.65.2.292 · Cited by 250 · see citing works
Keitel, V., Burdelski, M. M., Warskulat, U., Kühlkamp, T., KEPPLER, D. O. R., Häussinger, D., & Kubitz, R. (2005) · Hepatology · doi:10.1002/hep.20682 · Cited by 249 · see citing works
Farnesoid X Receptor Activates Transcription of the Phospholipid Pump MDR3
Huang, L., Zhao, A., Lew, J.-L., Zhang, T., Hrywna, Y., Thompson, J. R., de Pedro, N., Royo, I., Blevins, R. A., Peláez, F., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m308321200 · Cited by 248 · see citing works
Leuschner, M., Maier, K., Schlichting, J., Strahl, S., Herrmann, G., Dahm, H. H., Ackermann, H., Happ, J., & Leuschner, U. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70351-3 · Cited by 247 · see citing works
Zhang, J., Huang, W., Qatanani, M., Evans, R. M., & Moore, D. D. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m409041200 · Cited by 246 · see citing works
Transcriptional Regulation of the Human Sterol 12α-Hydroxylase Gene (CYP8B1)
Zhang, M., & Chiang, J. Y. L. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m105117200 · Cited by 244 · see citing works
Assem, M., Schuetz, E. G., Leggas, M. L., Sun, D., Yasuda, K., Reid, G., Zelcer, N., Adachi, M., Strom, S. C., Evans, R. M., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m314111200 · Cited by 240 · see citing works
Makino, I., HASHIMOTO, H., Shinozaki, K., et al. (1975) · Gastroenterology · doi:10.1016/s0016-5085(75)80094-1 · Cited by 239 · see citing works
Effects of long-term rifampicin administration in primary biliary cirrhosis
Bachs, L., Parés, A., Elena, M., Piera, C., & Rodés, J. (1992) · Gastroenterology · doi:10.1016/0016-5085(92)90335-v · Cited by 235 · see citing works
COMPARISON OF RIFAMPICIN WITH PHENOBARBITONE FOR TREATMENT OF PRURITUS IN BILIARY CIRRHOSIS
Bachs, L., Elena, M., Parés, A., Piera, C., & Rodés, J. (1989) · The Lancet · doi:10.1016/s0140-6736(89)91608-5 · Cited by 231 · see citing works
Kubitz, R., Wettstein, M., Warskulat, U., & Häussinger, D. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70138-1 · Cited by 228 · see citing works
A traditional herbal medicine enhances bilirubin clearance by activating the nuclear receptor CAR.
Huang, W.-D., Zhang, J., & Moore, D. (2004) · Journal of Clinical Investigation · doi:10.1172/jci18385 · Cited by 224 · see citing works
Rautiainen, H., Kärkkäinen, P., Karvonen, A., Nurmi, H., Pikkarainen, P., Nuutinen, H., & Färkkilä, M. (2005) · Hepatology · doi:10.1002/hep.20646 · Cited by 222 · see citing works
Moreau, A., Vilarem, M., Maurel, P., & Pascussi, J. (2007) · Molecular Pharmaceutics · doi:10.1021/mp700103m · Cited by 220 · see citing works
Zollner, G., & Trauner, M. A. (2008) · Clinics in Liver Disease · doi:10.1016/j.cld.2007.11.010 · Cited by 219 · see citing works
Self-citationPost, S. M., Duez, H., Gervois, P. P., Staels, B., Kuipers, F., & Princen, H. M. G. (2001) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/hq1101.098228 · Cited by 219 · see citing works
Nakata, K., Tanaka, Y., Nakano, T., Adachi, T., Tanaka, H., Kaminuma, T., & Ishikawa, T. (2006) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.21.437 · Cited by 215 · see citing works
The Farnesoid X Receptor Controls Gene Expression in a Ligand- and Promoter-selective Fashion
Lew, J.-L., Zhao, A., Yu, J., Huang, L., de Pedro, N., Peláez, F., Wright, S. D., & Cui, J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m306422200 · Cited by 215 · see citing works
Landrier, J., Eloranta, J. J., Vavricka, S. R., & Kullak-Ublick, G. A. (2005) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00430.2005 · Cited by 213 · see citing works
Cherrington, N. J., Hartley, D. P., Li, N., Johnson, D. R., & Klaassen, C. D. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.300.1.97 · Cited by 212 · see citing works
Li, T., & Chiang, J. Y. L. (2004) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00258.2004 · Cited by 212 · see citing works
Fabiani, E. D., Mitro, N., Gilardi, F., Caruso, D., Galli, G., & Crestani, M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m305079200 · Cited by 210 · see citing works
Dehydroepiandrosterone Sulfotransferase Gene Induction by Bile Acid Activated Farnesoid X Receptor
Song, C. S., Echchgadda, I., Baek, B. S., Ahn, S., Oh, T., Roy, A. K., & Chatterjee, B. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m107557200 · Cited by 208 · see citing works
A controlled trial of prednisolone treatment in primary biliary cirrhosis. Three-year results.
Mitchison, H., Palmer, J., Bassendine, M., Watson, A., Record, C., & James, O. (1992) · Journal of Hepatology · doi:10.1016/0168-8278(92)90065-w · Cited by 203 · see citing works
Modulation of human nuclear receptor LRH-1 activity by phospholipids and SHP
Ortlund, E. A., Lee, Y., Solomon, I. H., Hager, J., Safi, R., Choi, Y., Guan, Z., Tripathy, A., Raetz, C. R. H., McDonnell, D. P., et al. (2005) · Nature Structural & Molecular Biology · doi:10.1038/nsmb910 · Cited by 203 · see citing works
Barbier, O., Pineda‐Torra, I., Sirvent, A., Claudel, T., Blanquart, C., Durán-Sandoval, D., Kuipers, F., Kosykh, V., Fruchart, J., & Staels, B. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)00388-3 · Cited by 203 · see citing works
Hepatitis and liver dysfunction with rifampicin therapy for pruritus in primary biliary cirrhosis
Prince, M. I., Burt, A. D., & Jones, D. E. J. (2002) · Gut · doi:10.1136/gut.50.3.436 · Cited by 202 · see citing works
Dubuquoy, L., Dharancy, S., Nutten, S., Pettersson, S., Auwerx, J. H., & Desreumaux, P. (2002) · The Lancet · doi:10.1016/s0140-6736(02)11395-x · Cited by 197 · see citing works
Differential Regulation of Rat and HumanCYP7A1by the Nuclear Oxysterol Receptor Liver X Receptor-α
Goodwin, B. J., Watson, M. A., Kim, H., Miao, J., Kemper, J. K., & Kliewer, S. A. (2003) · Molecular Endocrinology · doi:10.1210/me.2002-0246 · Cited by 196 · see citing works
Fiorucci, S., Clerici, C., Antonelli, E., Orlandi, S., Goodwin, B. J., Sadeghpour, B. M., Sabatino, G., Russo, G., Castellani, D., Willson, T. M., et al. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.079665 · Cited by 196 · see citing works
Zollner, G., Fickert, P., Fuchsbichler, A., Silbert, D., Wagner, M., Arbeiter, S., Gonzalez, F. J., Marschall, H., Zatloukal, K., Denk, H., et al. (2003) · Journal of Hepatology · doi:10.1016/s0168-8278(03)00228-9 · Cited by 193 · see citing works
Self-citationNuclear Receptors and Drug Disposition Gene Regulation
Tirona, R. G., & Kim, R. B. (2005) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20324 · Cited by 193 · see citing works
A traditional herbal medicine enhances bilirubin clearance by activating the nuclear receptor CAR
Huang, W., Zhang, J., & Moore, D. D. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200418385 · Cited by 193 · see citing works
Hepatocyte Nuclear Factor 1α: A Key Mediator of the Effect of Bile Acids on Gene Expression
Jung, D., & Kullak-Ublick, G. A. (2003) · Hepatology · doi:10.1053/jhep.2003.50100 · Cited by 192 · see citing works
Chen, F. Y., Ananthanarayanan, M., Emre, S., Neimark, E., Bull, L. N., Knisely, A. S., Strautnieks, S. S., Thompson, R. J., Magid, M. S., Gordon, R. D., et al. (2004) · Gastroenterology · doi:10.1053/j.gastro.2003.12.013 · Cited by 191 · see citing works
Squires, E. J., Sueyoshi, T., & Negishi, M. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m407281200 · Cited by 188 · see citing works
Jung, D., Fantin, A. C., Scheurer, U., Fried, M., & Kullak-Ublick, G. A. (2003) · Gut · doi:10.1136/gut.53.1.78 · Cited by 188 · see citing works
Tian, J. M., & Schibler, U. (1991) · Genes & Development · doi:10.1101/gad.5.12a.2225 · Cited by 186 · see citing works
Marrapodi, M., & Chiang, J. Y. L. (2000) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)32398-1 · Cited by 185 · see citing works
Fabiani, E. D., Mitro, N., Anzulovich, A. C., Pinelli, A., Galli, G., & Crestani, M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m103270200 · Cited by 184 · see citing works
Fiorucci, S., Rizzo, G., Antonelli, E., Renga, B., Mencarelli, A., Riccardi, L., Orlandi, S., Pruzanski, M., Morelli, A., & Pellicciari, R. (2005) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.084905 · Cited by 183 · see citing works
Szatmári, I., Vámosi, G., Brázda, P., Bálint, B. L., Benkő, S., Széles, L., Jeney, V., Özvegy‐Laczka, C., Szántó, A., Barta, E., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m604890200 · Cited by 180 · see citing works
Zollner, G., Wagner, M., Moustafa, T., Fickert, P., Silbert, D., Gumhold, J., Fuchsbichler, A., Halilbasic, E., Denk, H., Marschall, H., et al. (2005) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00490.2005 · Cited by 180 · see citing works
Self-citationFXR regulates organic solute transporters α and β in the adrenal gland, kidney, and intestine
Lee, H. C., Zhang, Y., Lee, F. Y., Nelson, S. F., Gonzalez, F. J., & Edwards, P. A. (2005) · Journal of Lipid Research · doi:10.1194/jlr.m500417-jlr200 · Cited by 178 · see citing works
Fiorucci, S., Rizzo, G., Antonelli, E., Renga, B., Mencarelli, A., Riccardi, L., Morelli, A., Pruzanski, M., & Pellicciari, R. (2005) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.085597 · Cited by 177 · see citing works
The Involvement of the Pregnane X Receptor in Hepatic Gene Regulation during Inflammation in Mice
Teng, S., & Piquette‐Miller, M. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.076141 · Cited by 173 · see citing works
Sulphated and unsulphated bile acids in serum, bile, and urine of patients with cholestasis.
Henegouwen, G. P. V. B., Brandt, K. H., Eyssen, H., & Parmentier, G. G. (1976) · Gut · doi:10.1136/gut.17.11.861 · Cited by 172 · see citing works
Benefit of farnesoid X receptor inhibition in obstructive cholestasis
Stedman, C. A. M., Liddle, C., Coulter, S., Sonoda, J., Alvarez, J. G. A., Evans, R. M., & Downes, M. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0604772103 · Cited by 170 · see citing works
Jung, D., Fantin, A. C., Scheurer, U., Fried, M., & Kullak-Ublick, G. A. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)80515-2 · Cited by 170 · see citing works
Regulation of CYP3A4 by the bile acid receptor FXR
Gnerre, C., ttler, S. B., Kaufmann, M., Looser, R., & Meyer, U. (2004) · Pharmacogenetics · doi:10.1097/00008571-200410000-00001 · Cited by 169 · see citing works
Takeda, K., Ichiki, T., Tokunou, T., Funakoshi, Y., Iino, N., Hirano, K., Kanaide, H., & Takeshita, A. (2000) · Circulation · doi:10.1161/01.cir.102.15.1834 · Cited by 169 · see citing works
Nuclear receptor regulation of hepatic function
Karpen, S. J. (2002) · Journal of Hepatology · doi:10.1016/s0168-8278(02)00129-0 · Cited by 169 · see citing works
Pineda‐Torra, I., Jamshidi, Y., Flavell, D. M., Fruchart, J., & Staels, B. (2002) · Molecular Endocrinology · doi:10.1210/mend.16.5.0833 · Cited by 163 · see citing works
Kok, T., Bloks, V. W., Wolters, H., Havinga, R., Jansen, P. L. M., Staels, B., & Kuipers, F. (2003) · Biochemical Journal · doi:10.1042/bj20020981 · Cited by 161 · see citing works
Hepatocanalicular Transport Defects: Pathophysiologic Mechanisms of Rare Diseases
Elferink, R. P. J. O., Paulusma, C. C., & Groen, A. K. (2006) · Gastroenterology · doi:10.1053/j.gastro.2005.08.052 · Cited by 159 · see citing works
Echchgadda, I., Song, C. S., Roy, A. K., & Chatterjee, B. (2004) · Molecular Pharmacology · doi:10.1124/mol.65.3.720 · Cited by 156 · see citing works
Araya, Z., & Wikvall, K. (1999) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/s1388-1981(99)00031-1 · Cited by 154 · see citing works
Bile acid profiles in urine of patients with liver diseases
Bremmelgaard, A., & Sjövall, J. (1979) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1979.tb00894.x · Cited by 153 · see citing works
Lee, Y.-K., Schmidt, D. R., Cummins, C. L., Choi, M., Peng, L., Zhang, Y., Goodwin, B. J., Hammer, R. E., Mangelsdorf, D. J., & Kliewer, S. A. (2008) · Molecular Endocrinology · doi:10.1210/me.2007-0565 · Cited by 151 · see citing works
Bohan, A., Chen, W., Denson, L. A., Held, M. A., & Boyer, J. L. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m304011200 · Cited by 151 · see citing works
Repression of Farnesoid X Receptor during the Acute Phase Response
Kim, M. S., Shigenaga, J. K., Moser, A., Feingold, K. R., & Grünfeld, C. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212633200 · Cited by 151 · see citing works
Ding, X., Lichti-Kaiser, K., Kim, I., Gonzalez, F. J., & Staudinger, J. L. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m600931200 · Cited by 151 · see citing works
Activation of LXRs prevents bile acid toxicity and cholestasis in female mice
Uppal, H., Saini, S. P. S., Moschetta, A., Mu, Y., Zhou, J., Gong, H., Zhai, Y., Ren, S., Michalopoulos, G. K., Mangelsdorf, D. J., et al. (2007) · Hepatology · doi:10.1002/hep.21494 · Cited by 149 · see citing works
Differential glucuronidation of bile acids, androgens and estrogens by human UGT1A3 and 2B7
Gall, W. E., Zawada, G., Mojarrabi, B., Tephly, T. R., Green, M. D., Coffman, B. L., Mackenzie, P. I., & Radominska-p, A. (1999) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(99)00088-6 · Cited by 145 · see citing works
The crystal structures of human steroidogenic factor-1 and liver receptor homologue-1
Wang, W., Zhang, C., Marimuthu, A., Krupka, H. I., Tabrizizad, M., Shellooe, R., Mehra, U., Eng, K., Nguyen, H. T., Settachatgul, C., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409482102 · Cited by 145 · see citing works
Fibrates induce mdr2 gene expression and biliary phospholipid secretion in the mouse
José Chianale, B., Vollrath, V., Wielandt, A. M., Amigo, L., Rigotti, A., Nervi, F. O., González, S., ANDRADE, L., Pizarro, M., & Luigi Accatino, L. (1996) · Biochemical Journal · doi:10.1042/bj3140781 · Cited by 143 · see citing works
Barbier, O., Durán-Sandoval, D., Pineda‐Torra, I., Kosykh, V., Fruchart, J., & Staels, B. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m305361200 · Cited by 142 · see citing works
INDUCTION OF ABCC3 (MRP3) BY PREGNANE X RECEPTOR ACTIVATORS
Teng, S., Jekerle, V., & Piquette‐Miller, M. (2003) · Drug Metabolism and Disposition · doi:10.1124/dmd.31.11.1296 · Cited by 142 · see citing works
Novel pathways of bile acid metabolism involving CYP3A4
Bodin, K., Lindbom, U., & Diczfalusy, U. (2004) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2004.11.003 · Cited by 141 · see citing works
Mataki, C., Magnier, B. C., Houten, S. M., Annicotte, J., Argmann, C., Thomas, C., Overmars, H., Kulik, W., METZGER, D., Auwerx, J. H., et al. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.00852-07 · Cited by 141 · see citing works
Abnormal expression of anion exchanger genes in primary biliary cirrhosis
Prìeto, J., Qian, C., García, N., Dı́ez, J., & Medina, J. F. (1993) · Gastroenterology · doi:10.1016/0016-5085(93)90735-u · Cited by 140 · see citing works
Miura, T., Ouchida, R., Yoshikawa, N., Okamoto, K., Makino, Y., Nakamura, T., Morimoto, C., Makino, I., & Tanaka, H. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m107098200 · Cited by 137 · see citing works
Kamiya, A., Inoue, Y., & Gonzalez, F. J. (2003) · Hepatology · doi:10.1053/jhep.2003.50212 · Cited by 136 · see citing works
Ghose, R., Zimmerman, T. L., Thevananther, S., & Karpen, S. J. (2004) · Nuclear Receptor · doi:10.1186/1478-1336-2-4 · Cited by 134 · see citing works
Miquerol, L., López, S., Cartier, N., Tulliez, M., Raymondjean, M., & Kahn, A. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)37059-x · Cited by 133 · see citing works
del Castillo‐Olivares, A., & Gil, G. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m000996200 · Cited by 133 · see citing works
Eloranta, J. J., Jung, D., & Kullak-Ublick, G. A. (2005) · Molecular Endocrinology · doi:10.1210/me.2005-0159 · Cited by 131 · see citing works
Hepatoprotective role of PXR activation and MRP3 in cholic acid‐induced cholestasis
Teng, S., & Piquette‐Miller, M. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707235 · Cited by 130 · see citing works
Farnesoid X Receptor: From Structure to Potential Clinical Applications
Pellicciari, R., Costantino, G., & Fiorucci, S. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm0582221 · Cited by 130 · see citing works
Bezafibrate treatment: a new medical approach for PBC patients?
Kanda, T., Yokosuka, O., Imazeki, F., & Saisho, H. (2003) · Journal of Gastroenterology · doi:10.1007/s00535-002-1102-7 · Cited by 129 · see citing works
Bremmelgaard, A., & Sjövall, J. (1980) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)34768-4 · Cited by 129 · see citing works
Karpen, S. J., Sun, A., Kudish, B., Hagenbuch, B., Meier, P. J., Ananthanarayanan, M., & Suchy, F. J. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.25.15211 · Cited by 128 · see citing works
Almé, B., & Sjövall, J. (1980) · Journal of Steroid Biochemistry · doi:10.1016/0022-4731(80)90164-8 · Cited by 126 · see citing works
Zollner, G., Wagner, M., Fickert, P., Silbert, D., Gumhold, J., Zatloukal, K., Denk, H., & Trauner, M. A. (2007) · Liver International · doi:10.1111/j.1478-3231.2007.01506.x · Cited by 126 · see citing works
Self-citationSelective activation of liver X receptor alpha by 6α-hydroxy bile acids and analogs
Song, C. (2000) · Steroids · doi:10.1016/s0039-128x(00)00127-6 · Cited by 126 · see citing works
Falkner, K. C., Pinaire, J. A., Xiao, G., Geoghegan, T. E., & Prough, R. A. (2001) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)12625-9 · Cited by 126 · see citing works
Flagged first, then by citations
Research works printed but not linked: 6
- Inagaki T, Choi M, Moschetta A, Peng L, Cummins CL, McDonald JG Targeting nuclear receptors in cholestasis 22 G Zollner and M Trauner British Journal of Pharmacology (2009) 156 7-27
- Kamisako T, Adachi Y (1995). Marked improvement in cholestasis and hypercholesterolemia with simvastatin in a patient with primary biliary cirrhosis. Am J Gastroenterol 90 (7): 1187-1188.
- Kim I, Ahn SH, Inagaki T, Choi M, Ito S, Guo GL et al. (2007b). Differential regulation of bile acid homeostasis by the farnesoid X receptor in liver and intestine. J Lipid Res 48 (12): 2664-2672.
- Myant NB, Mitropoulos KA (1977). Cholesterol 7 alpha-hydroxylase. J Lipid Res 18 (2): 135-153.
- Odom DT, Zizlsperger N, Gordon DB, Bell GW, Rinaldi NJ, Murray HL Targeting nuclear receptors in cholestasis 24 G Zollner and M Trauner British Journal of Pharmacology (2009) 156 7-27
- Verreault M, Senekeo-Effenberger K, Trottier J, Bonzo JA, Belanger J, Targeting nuclear receptors in cholestasis 26 G Zollner and M Trauner British Journal of Pharmacology (2009) 156 7-27
Cited by
Sorted by citations
Bile acid-microbiota crosstalk in gastrointestinal inflammation and carcinogenesis
Jia, W., Xie, G., & Jia, W. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.119 · Cited by 1,924 · see citing works
Bile acid signaling in metabolic disease and drug therapy
Li, T., & Chiang, J. Y. L. (2014) · Pharmacological Reviews · doi:10.1124/pr.113.008201 · Cited by 935 · see citing works
New paradigms in the treatment of hepatic cholestasis: from UDCA to FXR, PXR and beyond
Beuers, U., Trauner, M., Jansen, P., & Poupon, R. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.02.023 · Cited by 537 · see citing works
Self-citationNovel therapeutic targets for cholestatic and fatty liver disease
Trauner, M., & Fuchs, C. D. (2022) · Gut · doi:10.1136/gutjnl-2021-324305 · Cited by 204 · see citing works
Self-citationThe challenges of primary biliary cholangitis: What is new and what needs to be done
Terziroli Beretta-Piccoli, B., Mieli-Vergani, G., Vergani, D., Vierling, J. M., Adams, D., Alpini, G., Banales, J. M., Beuers, U., Björnsson, E., Bowlus, C., et al. (2019) · Journal of Autoimmunity · doi:10.1016/j.jaut.2019.102328 · Cited by 114 · see citing works
Self-citationArrese, M., & Karpen, S. J. (2010) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2010.2 · Cited by 54 · see citing works
Nuclear receptors in liver fibrosis
Königshofer, P., Brusilovskaya, K., Petrenko, O., Hofer, B. S., Schwabl, P., Trauner, M., & Reiberger, T. (2021) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2021.166235 · Cited by 45 · see citing works
Self-citationThe new therapeutic frontier--nuclear receptors and the liver
Karpen, S. J., & Trauner, M. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2009.12.002 · Cited by 29 · see citing works
Self-citation
- Authors
- Zollner, G., & Trauner, M.
- Affiliations
- Medical University of Graz (AT)
- Corresponding author
- Trauner, Michael
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 2008-12-24
- Volume
- 156
- Issue
- 1
- Pages
- 7-27
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- PMC
- PMC2697779
- OpenAlex
- W2022838513
- Cited by
- 146
- References
- 304
- Citations by year
- 2026: 6 · 2025: 2 · 2024: 6 · 2023: 4 · 2022: 11 · 2021: 4 · 2020: 7 · 2019: 7 · 2018: 6 · 2017: 6 · 2016: 11 · 2015: 7 · 2014: 14 · 2013: 12 · 2012: 9
- FWCI
- 1.09
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- British Journal of Pharmacology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Health Sciences › Medicine › Surgery › Cholesterol and Lipid Metabolism
- Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
- Keywords
- nuclear receptors, cholestasis, cholestatic liver injury, farnesoid X receptor, pregnane X receptor, vitamin D receptor, constitutive androstane receptor, bile acid metabolism, bile acid transport, bile acid detoxification, hepatoprotection, liver fibrosis, liver cirrhosis, nuclear receptor agonists, ursodeoxycholic acid, pruritus, liver inflammation
- MeSH terms
- Bile Acids and Salts, Cholestasis, Chronic Disease, Humans, Ligands, Liver, Liver Cirrhosis, Receptors, Cytoplasmic and Nuclear
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review